Characterization of ApoJ-reconstituted high-density lipoprotein (rHDL) nanodisc for the potential treatment of cerebral β-amyloidosis
Year: 2017
Type: article
Abstract: Cerebral β-amyloidosis is a major feature of Alzheimer's disease (AD), characterized by the accumulation of β-amyloid protein (Aβ) in the brain. Several studies have implicated lipid/lipoprotein metabolism in the regulation of β-amyloidosis. In this regard, HDL (High Density Lipoprotein)-based therapies could ameliorate pathological features associated with AD. As apolipoprotein J (ApoJ) is a natural chaperone that interacts with Aβ, avoiding its aggregation and toxicity, in this study we propose to prepare reconstituted rHDL-rApoJ nanoparticles by assembling phospholipids with recombinant human ApoJ (rApoJ). Hence, rHDL particles were prepared using the cholate dialysis method and characterized by N-PAGE, dynamic light scattering, circular dichroism and electron transmission microscopy. The preparation of rHDL particles showed two-sized populations with discoidal shape. Functionally, rHDL-rApoJ maintained the ability to prevent the Aβ fibrillization and mediated a higher cholesterol efflux from cultured macrophages. Fluorescently-labelled rHDL-rApoJ nanoparticles were intravenously administrated in mice and their distribution over time was determined using an IVIS Xenogen® imager. It was confirmed that rHDL-rApoJ accumulated in the cranial region, especially in old transgenic mice presenting a high cerebral Aβ load. In conclusion, we have standardized a reproducible protocol to produce rHDL-rApoJ nanoparticles, which may be potentially considered as a therapeutic option for β-amyloid-related pathologies.
Source: Scientific Reports
Institutions: Universitat Autònoma de Barcelona, Vall d'Hebron Institut de Recerca, Consejo Superior de Investigaciones Científicas, Institut Català de Nanociència i Nanotecnologia, Barcelona Institute of Science and Technology, Hospital de Sant Pau, Institut de Recerca Sant Pau, Institució Catalana de Recerca i Estudis Avançats
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,690
Awards: G1335508357, Implicación de la apolipoproteína J (clusterina) en la arteriosclerosis. Utilización terapéutica de péptidos miméticos con actividad chaperona., G1894287339, G4886284, G5867070083, Marcadores radiológicos y biológicos de disfunción cerebrovascular en la Angiopatía Amiloide Cerebral
OpenAlex ID: W2765768250
